Midodrine (an 1-agonist) added to propranolol enabled higher -blocker dosing, achieving HVPG reduction of 23.5% versus 14.5% with propranolol alone and significantly lowering first-bleed risk in refractory ascites (Ranjan et al., Hepatol Int 2024)
Loss of weight, sodium and water in obese persons consuming a high- or low-carbohydrate diet
It also curbs ghrelin, the hunger hormone, creating a double-edged effect on appetite
Consistent intake helps maintain balance, not spikes
One study utilizing randomized, double-blind, placebo-controlled trials found that AOD 9604 had none of the adverse effects associated with HGH treatments, including impaired glucose tolerance
Add-On to Basal Insulin or Basal Insulin + MET) Efficacy of study medications on body weight in SUSTAIN-5 was presented in Table 34